CVS Health Corporation (CVS)

59.36
0.89 1.50
NYSE
Prev Close 60.25
Open 59.91
Day Low/High 58.67 / 59.98
52 Wk Low/High 52.04 / 77.03
Volume 7.54M
Exchange NYSE
Shares Outstanding 1308.70B
Market Cap 77.84B
P/E Ratio 9.45
Div & Yield N.A. (N.A)
Despite Virus Fears, Avoid Retail Pharmacy Stocks

Despite Virus Fears, Avoid Retail Pharmacy Stocks

With so many consumers preparing for a potential coronavirus outbreak, you might think that owning retail pharmacy stocks makes sense right now.

Three Strategies for Income Investors

Three Strategies for Income Investors

For reliable income, a portfolio strategy generating monthly payouts, an opportunity in dividend kings, and favorites among taxable bond funds.

3 Charts That Are Setting Up as Buy Opportunities

3 Charts That Are Setting Up as Buy Opportunities

KLA Corp. and Target already have triggered entry points, while CVS Health soon could.

Coronavirus Spreads, Reducing 'Big Oil', 4 Stocks to Watch, Adding Store Capital

Coronavirus Spreads, Reducing 'Big Oil', 4 Stocks to Watch, Adding Store Capital

Newly confirmed cases of the Covid-19 virus spiked from Hubei Province in China, where the city of Wuhan is located. The number of related deaths increased as well.

Jim Cramer: One Thing This Market Doesn't Lack Is Confidence

Jim Cramer: One Thing This Market Doesn't Lack Is Confidence

You can sell any stock that's up and take that money to the bank and no one will say, "sorry that was made off of euphoria, we can't take it."

On Becoming Risk-Averse, Sinking Baltic Dry Index, Fed Speak, Trading iQIYI

On Becoming Risk-Averse, Sinking Baltic Dry Index, Fed Speak, Trading iQIYI

We play the game in front of us. We try to excel in the environment provided.

Tech Based Rally, Real-Life Virus, Powell Speaks, Tracking 5 Stocks

Tech Based Rally, Real-Life Virus, Powell Speaks, Tracking 5 Stocks

This rally has been industry, not sector led, and it is all based on technology, whether or not market leaders reside within the Tech sector or not.

Teladoc Health Still Has Healthy Looking Charts and Indicators

Teladoc Health Still Has Healthy Looking Charts and Indicators

Teladoc said has been especially in demand this flu season.

Real Money Post Industrial Average Leads, but Coronavirus Adds Uncertainty

Real Money Post Industrial Average Leads, but Coronavirus Adds Uncertainty

RMPIA ended January up 0.8%, but now the damage from the Wuhan virus is weighing on the future.

Walgreens Today Looks a Lot Like CVS Last Spring

Walgreens Today Looks a Lot Like CVS Last Spring

While both companies appear like winners, WBA should have more to gain because of its discounted price.

Jim Cramer: The HQ for Innovation Is Right Here in San Francisco

Jim Cramer: The HQ for Innovation Is Right Here in San Francisco

The NYSE used to be the center of capitalism, but now it's where actual engineering, not financial engineering, is taking place.

Should You Be Preparing to Supplement Your Portfolio With More CVS Stock?

Should You Be Preparing to Supplement Your Portfolio With More CVS Stock?

Here's how two big events early this week make me view this name that's one of my favorite undervalued, dividend-paying companies.

Walgreens May Rally on Earnings, but CVS Looks Stronger

Walgreens May Rally on Earnings, but CVS Looks Stronger

The upcoming quarterly report for WBA might be a market mover, but the charts and indicators of CVS show a healthy stock ready to rise.

Market Prices in New Risk, Action for 9 Stocks in My Portfolio: Market Recon

Market Prices in New Risk, Action for 9 Stocks in My Portfolio: Market Recon

What I suggest individual investors do is give their portfolios a physical. Like a visit to the doctor.

Plenty of Reasons to Remain Bullish on Real Money Post Industrial Average

Plenty of Reasons to Remain Bullish on Real Money Post Industrial Average

Let's review 2019 performance of RMPIA in relation to stock indexes and see what's ahead.

My Pick for 2020? You Won't Believe It's Been on Your Screen All Along

My Pick for 2020? You Won't Believe It's Been on Your Screen All Along

This company made headlines in 2019, and I'm betting on it as a great play -- in many senses of the word -- for this new year.

Individual Investors Are Back! Trading Cisco: Market Recon

Individual Investors Are Back! Trading Cisco: Market Recon

It seemed to happen overnight. People watched. People listened. People cared. About what? Individual stocks.

Jim Cramer: The Market's Judgment on Price Isn't Perfect

Jim Cramer: The Market's Judgment on Price Isn't Perfect

Wrong valuations -- such as those in Conagra Brands and Rite Aid -- exist, and they can make you money.

3 Thoughts About UnitedHealth and My Trade Idea

3 Thoughts About UnitedHealth and My Trade Idea

There is no doubt in my mind that the firm is executing at a high level.

RMPIA Lags in November, but Trounces S&P 500 for Quarter, Year So Far

RMPIA Lags in November, but Trounces S&P 500 for Quarter, Year So Far

Now, many Real Money Post Industrial Average stocks should see a boost from the holiday splurge by shoppers.

Jim Cramer: Stop Speculating on Deals

Jim Cramer: Stop Speculating on Deals

I'm all in favor of mergers and acquisitions -- the more we get, the higher the stock market goes -- but I am not in favor of making conclusions based on tips about deals.

CVS Hit One Out of the Park, Here's My Plan

CVS Hit One Out of the Park, Here's My Plan

I like the name, and I like the progress that CVS is making. This stock can go higher.

CVS Health Continues to Improve With Stronger Charts and Fundamentals, Too

CVS Health Continues to Improve With Stronger Charts and Fundamentals, Too

Even before reporting better-than-expected third-quarter results, the pharmacy giant was seeing more aggressive buying of its shares.

U.S. Treasury Yield Curve, Oil Market Valuations, Trading Adobe: Market Recon

U.S. Treasury Yield Curve, Oil Market Valuations, Trading Adobe: Market Recon

OPEC forecasts declining demand for OPEC oil, not a decline in global demand. That distinction is key.

The Week Ahead: Earnings Season Is Far From Over

The Week Ahead: Earnings Season Is Far From Over

Disney, Qualcomm and Square are among 75 key reports we are watching.

It's Settled: CVS Health Is Headed Up to $80

It's Settled: CVS Health Is Headed Up to $80

Charts and indicators agree with Jim Cramer's bullish year-end call.

Jim Cramer: The Market Is Lapping Up These Stocks

Jim Cramer: The Market Is Lapping Up These Stocks

There are plenty of senior growth companies that can still move higher.

Real Money Post-Industrial Average Continues to Outpace Major Indices

Real Money Post-Industrial Average Continues to Outpace Major Indices

RMPIA is up 20.9% in the first nine months of 2019.

Jim Cramer: Watch for Stocks Reporting 'Not as Bad as Feared' Numbers

Jim Cramer: Watch for Stocks Reporting 'Not as Bad as Feared' Numbers

When you have an oversold market you've got a true coiled spring that can rally beyond where it might ordinary go on good news.

Jim Cramer: Here's Why the Market's So Feckless and Reactive

Jim Cramer: Here's Why the Market's So Feckless and Reactive

So many companies -- like Netflix, Facebook and Johnson & Johnson -- are not trading on earnings per share, but on factors that are nearly impossible to quantify.